cartilage degeneration osteoarthritis
Conditions
Interventions
None listed
Sponsors
Moleculaire Epidemiologie
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Patients above 40 years of age that are eligable for a total knee or hip replacement. - Joint replacements is due to end stage osteoarthritis
Exclusion criteria
Exclusion criteria: -Patients that are obtaining a total knee or hip replacement due to other causes then osteoarthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In order to assess functional effects of OA susceptibility genes in the relavant disesed tissue in comparison to blood by: Monitoring of RNA expression profiles in diseased tissue and blood. Differential allelic expression of susceptibility alleles in diseased tissue and blood | — |
Secondary
| Measure | Time frame |
|---|---|
| Increased knowledge on the OA etiology will allow, in the future, new drugable targets, better prevention, prognosis and disease management. | — |
Countries
Netherlands
Outcome results
None listed